Cargando…
PB2679: MIXED-METHOD, CROSS-SECTIONAL SURVEY TO DESCRIBE FEELINGS, PERCEPTION, AND EXPERIENCE OF MULTIPLE MYELOMA PATIENTS WHO SWITCHED FROM INTRAVENOUS DARATUMUMAB TO THE SUBCUTANEOUS FORMULATION IN EUROPE
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429322/ http://dx.doi.org/10.1097/01.HS9.0000977392.89675.82 |
| _version_ | 1785090682852999168 |
|---|---|
| author | Magarotto, Valeria Thevenon, Julien Morgan, Kate Seldam, Silene Ten Iraqi, Wafae Guillaume, Xavier Horchi, Dahbia Rault, Bleuenn Gruppe, Traugott Ludwig |
| author_facet | Magarotto, Valeria Thevenon, Julien Morgan, Kate Seldam, Silene Ten Iraqi, Wafae Guillaume, Xavier Horchi, Dahbia Rault, Bleuenn Gruppe, Traugott Ludwig |
| author_sort | Magarotto, Valeria |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429322 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104293222023-08-17 PB2679: MIXED-METHOD, CROSS-SECTIONAL SURVEY TO DESCRIBE FEELINGS, PERCEPTION, AND EXPERIENCE OF MULTIPLE MYELOMA PATIENTS WHO SWITCHED FROM INTRAVENOUS DARATUMUMAB TO THE SUBCUTANEOUS FORMULATION IN EUROPE Magarotto, Valeria Thevenon, Julien Morgan, Kate Seldam, Silene Ten Iraqi, Wafae Guillaume, Xavier Horchi, Dahbia Rault, Bleuenn Gruppe, Traugott Ludwig Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429322/ http://dx.doi.org/10.1097/01.HS9.0000977392.89675.82 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Magarotto, Valeria Thevenon, Julien Morgan, Kate Seldam, Silene Ten Iraqi, Wafae Guillaume, Xavier Horchi, Dahbia Rault, Bleuenn Gruppe, Traugott Ludwig PB2679: MIXED-METHOD, CROSS-SECTIONAL SURVEY TO DESCRIBE FEELINGS, PERCEPTION, AND EXPERIENCE OF MULTIPLE MYELOMA PATIENTS WHO SWITCHED FROM INTRAVENOUS DARATUMUMAB TO THE SUBCUTANEOUS FORMULATION IN EUROPE |
| title | PB2679: MIXED-METHOD, CROSS-SECTIONAL SURVEY TO DESCRIBE FEELINGS, PERCEPTION, AND EXPERIENCE OF MULTIPLE MYELOMA PATIENTS WHO SWITCHED FROM INTRAVENOUS DARATUMUMAB TO THE SUBCUTANEOUS FORMULATION IN EUROPE |
| title_full | PB2679: MIXED-METHOD, CROSS-SECTIONAL SURVEY TO DESCRIBE FEELINGS, PERCEPTION, AND EXPERIENCE OF MULTIPLE MYELOMA PATIENTS WHO SWITCHED FROM INTRAVENOUS DARATUMUMAB TO THE SUBCUTANEOUS FORMULATION IN EUROPE |
| title_fullStr | PB2679: MIXED-METHOD, CROSS-SECTIONAL SURVEY TO DESCRIBE FEELINGS, PERCEPTION, AND EXPERIENCE OF MULTIPLE MYELOMA PATIENTS WHO SWITCHED FROM INTRAVENOUS DARATUMUMAB TO THE SUBCUTANEOUS FORMULATION IN EUROPE |
| title_full_unstemmed | PB2679: MIXED-METHOD, CROSS-SECTIONAL SURVEY TO DESCRIBE FEELINGS, PERCEPTION, AND EXPERIENCE OF MULTIPLE MYELOMA PATIENTS WHO SWITCHED FROM INTRAVENOUS DARATUMUMAB TO THE SUBCUTANEOUS FORMULATION IN EUROPE |
| title_short | PB2679: MIXED-METHOD, CROSS-SECTIONAL SURVEY TO DESCRIBE FEELINGS, PERCEPTION, AND EXPERIENCE OF MULTIPLE MYELOMA PATIENTS WHO SWITCHED FROM INTRAVENOUS DARATUMUMAB TO THE SUBCUTANEOUS FORMULATION IN EUROPE |
| title_sort | pb2679: mixed-method, cross-sectional survey to describe feelings, perception, and experience of multiple myeloma patients who switched from intravenous daratumumab to the subcutaneous formulation in europe |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429322/ http://dx.doi.org/10.1097/01.HS9.0000977392.89675.82 |
| work_keys_str_mv | AT magarottovaleria pb2679mixedmethodcrosssectionalsurveytodescribefeelingsperceptionandexperienceofmultiplemyelomapatientswhoswitchedfromintravenousdaratumumabtothesubcutaneousformulationineurope AT thevenonjulien pb2679mixedmethodcrosssectionalsurveytodescribefeelingsperceptionandexperienceofmultiplemyelomapatientswhoswitchedfromintravenousdaratumumabtothesubcutaneousformulationineurope AT morgankate pb2679mixedmethodcrosssectionalsurveytodescribefeelingsperceptionandexperienceofmultiplemyelomapatientswhoswitchedfromintravenousdaratumumabtothesubcutaneousformulationineurope AT seldamsileneten pb2679mixedmethodcrosssectionalsurveytodescribefeelingsperceptionandexperienceofmultiplemyelomapatientswhoswitchedfromintravenousdaratumumabtothesubcutaneousformulationineurope AT iraqiwafae pb2679mixedmethodcrosssectionalsurveytodescribefeelingsperceptionandexperienceofmultiplemyelomapatientswhoswitchedfromintravenousdaratumumabtothesubcutaneousformulationineurope AT guillaumexavier pb2679mixedmethodcrosssectionalsurveytodescribefeelingsperceptionandexperienceofmultiplemyelomapatientswhoswitchedfromintravenousdaratumumabtothesubcutaneousformulationineurope AT horchidahbia pb2679mixedmethodcrosssectionalsurveytodescribefeelingsperceptionandexperienceofmultiplemyelomapatientswhoswitchedfromintravenousdaratumumabtothesubcutaneousformulationineurope AT raultbleuenn pb2679mixedmethodcrosssectionalsurveytodescribefeelingsperceptionandexperienceofmultiplemyelomapatientswhoswitchedfromintravenousdaratumumabtothesubcutaneousformulationineurope AT gruppetraugottludwig pb2679mixedmethodcrosssectionalsurveytodescribefeelingsperceptionandexperienceofmultiplemyelomapatientswhoswitchedfromintravenousdaratumumabtothesubcutaneousformulationineurope |